Ocugen, Inc. OCGN
1.02
0.02
2.00%
as of 25 Sep
- Market cap
- $339.1M
- P/E
- 0.0×
Follow OCGN
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 1,211.66% | (660.00%) | (776.89%) | (289.93%) |
+8 more TTM periods Free account |
|
| (92.03%) | (118.11%) | (107.73%) | (107.12%) | ||
ROIC |
0.00% | (1,317.07%) | 0.00% | 0.00% | |
Return on Tangible Assets |
628.74% | (226.29%) | (432.44%) | (198.67%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.18) | (0.18) | (0.19) | (0.18) | |
Free Cash Flow |
(61.02) | (59.58) | (57.15) | (53.53) | |
Capital Expenditures |
(0.15) | (0.17) | (0.18) | (0.16) | |
Piotroski F-Score |
3.00 | 1.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(71.41%) | (88.85%) | (161.84%) | (82.74%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
955.55% | 928.91% | 900.75% | 695.90% | |
Selling, General and Administrative Expense of Revenue |
648.89% | 654.94% | 624.95% | 516.96% | |
Share Based Compensation of Revenue |
201.05% | 206.49% | 174.64% | 141.17% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.74 | 0.83 | 0.84 | 0.83 | |
Depreciation/Fixed assets |
0.40 | 0.28 | 0.26 | 0.23 | |
Capex/Depreciation |
(0.03) | (0.05) | (0.05) | (0.05) | |
Revenue per Share |
0.01 | 0.01 | 0.01 | 0.02 | |
Operating CF per Share |
(0.18) | (0.18) | (0.19) | (0.18) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.03 | |
Net Profit Margin |
(1,786.27%) | (1,605.22%) | (1,537.41%) | (1,192.18%) |
Columns are period end dates